X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medicin och hälsovetenskap (232) 232
medical and health sciences (230) 230
kardiologi (176) 176
cardiac and cardiovascular systems (174) 174
clinical medicine (163) 163
klinisk medicin (163) 163
humans (159) 159
male (141) 141
female (134) 134
cardiac & cardiovascular systems (121) 121
middle aged (121) 121
aged (117) 117
myocardial infarction (84) 84
risk factors (84) 84
coronary heart disease (65) 65
mortality (64) 64
abridged index medicus (61) 61
acute coronary syndromes (56) 56
treatment outcome (56) 56
clopidogrel (53) 53
stroke (53) 53
cardiovascular (50) 50
care and treatment (49) 49
heart attacks (49) 49
cardiovascular disease (48) 48
double-blind method (48) 48
prognosis (45) 45
risk (45) 45
acute coronary syndrome (37) 37
myocardial-infarction (36) 36
follow-up studies (35) 35
outcomes (35) 35
atrial fibrillation (34) 34
cardiac patients (34) 34
coronary artery disease (33) 33
acute coronary syndrome - drug therapy (31) 31
ticagrelor (31) 31
drug therapy (28) 28
secondary prevention (28) 28
adult (27) 27
cardiology (27) 27
internal medicine (27) 27
patient outcomes (27) 27
prospective studies (27) 27
bleeding (26) 26
medicine (26) 26
risk assessment (26) 26
biomarkers (25) 25
cardiovascular diseases (25) 25
clinical trials (25) 25
time factors (25) 25
angina pectoris (24) 24
aspirin (24) 24
hemorrhage - chemically induced (24) 24
medicin (24) 24
platelet aggregation inhibitors - therapeutic use (24) 24
analysis (23) 23
medical research (23) 23
heart attack (22) 22
proportional hazards models (22) 22
therapy (22) 22
association (21) 21
diabetes (21) 21
prevention (21) 21
psychology (21) 21
adenosine - analogs & derivatives (20) 20
coronary vessels (20) 20
electrocardiography (20) 20
kaplan-meier estimate (20) 20
medicine, general & internal (20) 20
psykologi (20) 20
acute coronary syndrome - mortality (19) 19
incidence (19) 19
medicine, experimental (19) 19
peripheral vascular disease (19) 19
platelet aggregation inhibitors - adverse effects (19) 19
death (18) 18
metaanalysis (18) 18
stroke - prevention & control (18) 18
cardiac rehabilitation (17) 17
cause of death (17) 17
hemorrhage (17) 17
management (17) 17
ticlopidine - analogs & derivatives (17) 17
usage (17) 17
apixaban (16) 16
atherosclerosis (16) 16
dosage and administration (16) 16
inflammation (16) 16
ischemia (16) 16
samhällsvetenskap (16) 16
social sciences (16) 16
depression (15) 15
health risk assessment (15) 15
health sciences (15) 15
heart diseases (15) 15
thrombin (15) 15
acute myocardial-infarction (14) 14
aged, 80 and over (14) 14
anxiety (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10035, pp. 2302 - 2311
Journal Article
Upsala journal of medical sciences, ISSN 2000-1967, 2018, Volume 124, Issue 1, pp. 42 - 45
Clinical endpoint adjudication (CEA) is a standardized process for assessment of safety and efficacy of pharmacologic or device therapies in clinical trials.... 
Adjudication | endpoints | clinical trials | BIVALIRUDIN | DEFINITIONS | MEDICINE, GENERAL & INTERNAL | THROMBUS ASPIRATION | COMMITTEE | HEPARIN | ELEVATION MYOCARDIAL-INFARCTION | REGISTRY | Clinical trials | adjudication
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 21, pp. 1995 - 2008
In this randomized, placebo-controlled trial, investigators evaluated the effects of the sodium–glucose cotransporter 2 inhibitor dapagliflozin in patients... 
NEPRILYSIN INHIBITION | OUTCOMES | COTRANSPORTER 2 INHIBITORS | MECHANISM | EMPAGLIFLOZIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR OUTCOMES | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Heart Failure - complications | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Combined Modality Therapy | Hospitalization | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Ventricular Dysfunction, Left - drug therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Measurement | Heart failure | Dapagliflozin | Patient outcomes | Physiological aspects | Cardiac output | Drug therapy | Testing | Intravenous administration | Renal function | Clinical trials | Hypoglycemia | Evidence-based medicine | Clinical outcomes | Sodium | Hemoglobin | Patient safety | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Ejection fraction | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 11, pp. 1045 - 1057
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 21, pp. 2021 - 2031
Journal Article
The American heart journal, ISSN 0002-8703, 2015, Volume 169, Issue 6, pp. 899 - 905.e1
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 21, pp. 2009 - 2020
Journal Article